文献速递乳腺癌支持与姑息治疗

早期乳腺癌患者EORTC QLQ-C30和EORTC QLQ-BR23的真实世界参考评分

Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients.
PubMed 文献 · Eur J Cancer · 2022-01-20

该研究基于柏林夏里特大学医学院乳腺中心2016至2021年数字PRO项目数据,纳入1478例患者,其中729例为浸润性乳腺癌或导管原位癌,270例纤维腺瘤,479例其他乳腺疾病;采用调整线性回归和变量离散β回归比较诊断组。乳腺癌患者在除角色功能、性功能和体象外的几乎所有领域评分更差,与既往早期乳腺癌参考评分相比,情感和认知功能受影响更明显。

要点

  • 乳腺癌患者在除角色功能、性功能和体象外的几乎所有领域PRO评分更差。
  • 与既往早期乳腺癌参考评分相比,当前数据中情感和认知功能受影响更明显。
  • 研究结果有助于PRO解读并促进其在临床实践和临床试验中的应用。

核心结论

  • 研究结果为PRO解读提供高价值参考,促进其在临床实践和临床试验中的应用。
  • 评分提示在治疗前迫切需要心理社会支持。

研究设计与样本

  • 回顾性分析2016至2021年柏林夏里特大学医学院乳腺中心数字PRO项目中门诊患者数据。
  • 纳入1478例患者,其中729例浸润性乳腺癌或导管原位癌,270例纤维腺瘤,479例其他乳腺疾病。
  • 采用调整线性回归和变量离散β回归模型比较不同诊断组。

主要发现

  • 乳腺癌患者在除角色功能、性功能和体象外的几乎所有领域报告更差评分。
  • 与既往发表的早期乳腺癌参考评分相比,当前数据对情感和认知功能的影响更明显。

临床怎么用

  • 作者认为研究结果有助于PRO解读并促进其在临床实践和临床试验中的应用。
  • 作者指出评分提示在治疗前迫切需要心理社会支持。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To deliver patient-reported outcome (PRO) reference data for breast cancer and various other breast diseases to facilitate the interpretation of PRO scores during routine breast cancer treatment. METHODS: To determine reference baseline values for the PRO measures EORTC QLQ-C30 and EORTC QLQ-BR23, PRO data captured in the breast cancer centre at Charité - Universitätsmedizin Berlin from 2016 to 2021 were evaluated. As part of the clinical routine, ambulatory patients were asked to answer a digital survey regarding their medical history, current health status and health-related quality of life using the aforementioned questionnaires prior to their doctor's appointment in the outpatient breast clinic. Adjusted linear and variable dispersion beta regression models were used to compare different diagnosis groups. RESULTS: A total of 3689 patients were included in the digital PRO program, of which 1478 were eligible for this study; 729 had invasive breast cancer or ductal carcinoma in situ, 270 patients were diagnosed with fibroadenoma and 479 patients had other breast diseases such as cysts, mastopathy or abscesses. Overall, patients with breast cancer reported worse scores in almost all domains except for role functioning, sexual functioning and body image. Compared to previously published reference scores for early breast cancer, the current data show a more pronounced impact on perceived emotional and cognitive functioning. CONCLUSION: The results of this study are of high value for the interpretation of PROs and facilitate their use in clinical practice and clinical trials. The scores indicate an urgent need for psychosocial support prior to treatment.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Karsten MM, Roehle R, Albers S, et al. Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients. Eur J Cancer. 2022. PMID: 35066338. doi:10.1016/j.ejca.2021.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。